Actilight® and Immune stimulation

Through the modulation of the gut flora, the fermentation and the changes in the colonic environment, Actilight®’s short-chain fructo-oligosaccharides have a major influence on key factors related to resistance to human diseases, such as inflammation or colon cancer. Indeed, Actilight® has potentialities to:

• Reduce the colonization of the intestine by potentially pathogenic bacteria
• Interact with the intestinal immune system
• Modulate cellular events important for cancer prevention